Title |
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study
|
---|---|
Published in |
BMC Neurology, October 2012
|
DOI | 10.1186/1471-2377-12-124 |
Pubmed ID | |
Authors |
Marta Giannini, Emilio Portaccio, Angelo Ghezzi, Bahia Hakiki, Luisa Pastò, Lorenzo Razzolini, Elisa Piscolla, Laura De Giglio, Carlo Pozzilli, Damiano Paolicelli, Maria Trojano, Maria Giovanna Marrosu, Francesco Patti, Loredana La Mantia, Gianluigi Mancardi, Claudio Solaro, Rocco Totaro, Maria Rosaria Tola, Giovanna De Luca, Alessandra Lugaresi, Lucia Moiola, Vittorio Martinelli, Giancarlo Comi, Maria Pia Amato |
Abstract |
Only few studies have assessed safety of in utero exposure to glatiramer acetate (GA). Following a previous study assessing the safety of interferon beta (IFNB) pregnancy exposure in multiple sclerosis (MS), we aimed to assess pregnancy and fetal outcomes after in utero exposure to GA, using the same dataset, with a specific focus on the risk of spontaneous abortion. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 29% |
Australia | 1 | 14% |
Egypt | 1 | 14% |
Unknown | 3 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 86% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 91 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 13% |
Other | 11 | 12% |
Student > Master | 11 | 12% |
Researcher | 9 | 10% |
Student > Bachelor | 6 | 7% |
Other | 22 | 24% |
Unknown | 20 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 42% |
Neuroscience | 8 | 9% |
Agricultural and Biological Sciences | 4 | 4% |
Nursing and Health Professions | 4 | 4% |
Psychology | 3 | 3% |
Other | 10 | 11% |
Unknown | 24 | 26% |